Elutia, Inc. - Class A Common Stock (NQ:ELUT)

0.7859 +0.0059 (+0.76%)

Delayed Quote Updated: 12:56 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elutia, Inc. - Class A Common Stock

< Previous 1 2 Next >

Elutia (ELUT) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

CEO Mills reports 96% surgeon interest in NXT-41x platform ahead of late 2026 FDA clearance.

Via The Motley Fool

Topics Earnings

Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.

August 18, 2026

Acquisition expands Cellution Biologics’ human tissue-based portfolio and marks its entry into the U.S. reconstructive surgery market

From Cellution Biologics

Via GlobeNewswire

Elutia Q2 2026 Earnings Call Transcript ↗

August 13, 2026

On Thursday, Elutia (NASDAQ:ELUT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For...

Via Benzinga

Topics Earnings

Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity ↗

July 17, 2026

Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance sheet ahead of the NXT-41x launch.

Via Benzinga

Elutia Inc (NASDAQ:ELUT) Reports Q4 Revenue Miss Amid Key FDA Submission for NXT-41 ↗

March 11, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

Issued on behalf of Conexeu Sciences Inc.

From World Street Intelligence

Via GlobeNewswire

Elutia (ELUT) Q1 2026 Earnings Transcript ↗

May 15, 2026

Elutia (ELUT) Q1 2026 Earnings Transcript

Via The Motley Fool

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

April 30, 2026

From TELA Bio, Inc.

Via GlobeNewswire

SWK Holdings Provides Portfolio Update

October 17, 2024

Via ACCESSWIRE

Recap: Elutia Q4 Earnings ↗

March 07, 2024

Via Benzinga

Elutia (ELUT) Q4 2025 Earnings Call Transcript ↗

March 11, 2026

Elutia (ELUT) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

These stocks that are showing activity before the opening bell on Friday. ↗

October 03, 2025

Wondering what's happening in Friday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 29, 2025

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 09, 2025

Via Benzinga

Elutia (ELUT) Q2 2025 Earnings Call Transcript ↗

August 14, 2025

Via The Motley Fool

Topics Earnings Lawsuit

Elutia Posts Narrower Loss in Fiscal Q2 ↗

August 14, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 15, 2025

Via Benzinga

ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q2 2024 ↗

August 07, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

July 17, 2024

Via ACCESSWIRE

7 Growth Stocks to Buy for Under $5 for Massive Gains ↗

July 11, 2024

Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 17, 2024

Via Benzinga

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 11, 2024

Via Benzinga

ELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023 ↗

March 07, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.